TX-COGNITIVE-SPACE
8.12.2021 04:42:05 CET | Business Wire | Press release
Cognitive Space announced the highlights of a very successful year in its mission to dramatically improve the way we monitor the Earth for economic, environmental, and national security understanding. The company helps organizations fly their satellites with new tools for New Space - providing satellite operators and space infrastructure companies with sophisticated SaaS services for optimizing revenue and performance yield, forecasting future capacity, and orchestrating collection management as satellite constellations grow and scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207006237/en/
“The New Space economy is attracting massive investment and is growing exponentially. Space will be filled with thousands of new commercial satellites,” said Scott Herman, CEO of Cognitive Space. “But building out the required ground architecture is a major hurdle for New Space companies and usually represents a significant monetary investment, a multi-year time commitment, and major execution risk as they build their business. Cognitive Space provides a blueprint and an operational capability that de-risks and accelerates their buildout schedule, controls costs, and then optimizes their ongoing operations to power their business vision.”
2021 Highlights for Cognitive Space:
$5.5M in Investment Capital raised – Cognitive Space started the year with a $1.5M “pre-seed” raise, followed in November with the closing of a $4M Series Seed led by Grit Ventures of Menlo Park. Additional investors include Argon Ventures, Techstars, UltraTech Capital Partners, Cultivation Capital, Glasswing Ventures, Gutbrain Ventures, PBJ Capital, SpaceFund, and Deep Ventures. Outside counsel for the transaction were Covington and Burling LLP. As a result of this 2021 fundraising effort, Cognitive Space enters 2022 with $5.5M in funds ready to apply towards commercial product development and company growth.
“Billions of investment dollars are flowing into the New Space economy. There is an unmet imperative for cost-effective, scalable, and business-savvy constellation operations,” commented Jennifer Gill Roberts, Managing Partner at Grit Ventures. “We believe Cognitive Space's AI-driven approach to maximizing constellation revenue and performance yield gives their customers a significant competitive advantage in this emerging market for Space-based services.”
New and expanded US Government contracts – Cognitive Space continued its work with several US Government agencies, including the US Space Force, the Air Force Research Lab (AFRL), the National Geospatial Intelligence Agency (NGA), and other members of the national security community. In these engagements Cognitive Space focused on concept development and rapid prototyping for topics such as orchestrated collection management, hybrid space architecture, and global monitoring. Of particular note, Cognitive Space was selected as a winner of the Space Force Pitch Day competition, resulting in a $1.7M contract for exploring new approaches to satellite operations using Artificial Intelligence.
Cognitive Space also supported several US Government exercises, including RIMPAC, Northern Edge, and Joint Warrior. The company orchestrated collection opportunities across multiple commercial and government suppliers of satellite remote sensing. Cognitive Space provided the US Government with insight into the emerging wave of commercial remote sensing capabilities, helping them understand the impact of these capabilities on future operations, tradecraft, tools, and procurement methods.
Commercial Sales Traction – This summer, Cognitive Space introduced its SaaS-based platform for autonomous and dynamic satellite operations to a growing set of commercial satellite operators and space infrastructure companies. The platform revolutionizes satellite operations with the power of artificial intelligence for mission management, collections planning, and communications link coordination. The suite is available in versions tailored for startups, growth, and enterprise-class customers in the New Space domain.
Strong Revenue growth – Cognitive Space continues to dramatically increase its year-over-year revenue with new contracts, solid bookings, and a dense opportunity pipeline going into 2022.
Accelerator Wins – Cognitive Space was competitively selected for several startup accelerators, including the Amazon Web Services (AWS) Seraphim Space Accelerator and the NGA Startup Accelerator. As one of 10 companies chosen by AWS out of a field of approximately 200 startups, Cognitive Space received $100,000 in cloud infrastructure credits, AWS Cloud training and support, mentorship, and additional business development resources including opportunities to speak with space-savvy venture investors. With the NGA Accelerator, Cognitive Space has been working with government analysts on a pilot project exploring the role of future commercial satellite capabilities for facility monitoring and pattern-of-life analytics in real-world scenarios.
Building the best team in AI-driven Satellite Operations – Cognitive Space continues to recruit aggressively for an expanding team of AI/ML scientists and mathematicians, satellite and aerospace engineers, full-stack and frontend/backend developers, system architects, and Cloud DevOps engineers. In 2021, the company also made strategic additions to the executive team by recruiting senior industry veterans Scott Herman (as CEO) and Hanna Steplewska (as VP, Business Development & Operations). Scott and Hanna bring deep experience in Space Operations, Satellite Remote Sensing, Geospatial Analytics, and National Security and a comprehensive understanding of the New Space ecosystem.
About Cognitive Space
More information about Cognitive Space can be found at http://www.cognitivespace.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207006237/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom